LexDanaLexDanabeta
Inventor

Neil Moss

Inventor
Ridgefield, CT, US

Overview

34→
Patents
1995–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes18%
C07KPeptides10%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change4%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,849,901Arf6 inhibitors and methods of synthesis and use thereof20208,609,696'Serotonin 5-HT2B receptor inhibitors'20138,552,205'Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides'20137,790,712'Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors'20107,550,461'Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases'20097,470,692'Cytokine inhibitors'20087,335,657'Cytokine inhibitors'20087,279,475'Fluorinated di-aryl urea compounds'20077,211,575'Methods of treating cytokine mediated diseases'20077,115,644'Heterocyclic compounds'20067,078,419'Cytokine inhibitors'20066,916,814'Methods of treating cytokine mediated diseases'20056,872,726'Fluorinated di-aryl urea compounds'20056,852,717'Compounds useful as anti-inflammatory agents'20056,844,435'Heterocyclic compounds useful as inhibitors of tyrosine kinases'20056,770,639'Heterocyclic compounds useful as inhibitors of tyrosine kinases'20046,765,009'1,4-Disubstituted benzo-fused compounds'20046,660,732'Compounds useful as anti-inflammatory agents'20036,506,769'Heterocyclic compounds useful as inhibitors of tyrosine kinases'20036,489,328'Heterocyclic compounds useful as inhibitors of tyrosine kinases'20026,313,095'Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain'20016,284,768'Src family SH2 domain inhibitors'20016,268,365'Src family SH2 domain inhibitors'20016,228,881'Aromatic heterocyclic compounds and their use as anti-inflammatory agents'20016,156,784'Compounds useful as phosphotyrosine mimics'20006,080,763'Aromatic heterocyclic compounds and their use as anti-inflammatory agents'20006,054,470'Src family SH2 domain inhibitors'20005,846,941'Isosteric antiherpes peptide derivatives II'19985,830,864'Antiherpes peptide derivatives having a ureido n-terminus'19985,672,586'Herpes ribonucleotide reductase inhibitors'19975,574,015'Isosteric antiherpes peptide derivatives'19965,502,036'Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain'19965,484,771'Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus'19965,476,841'Inhibitors of herpes viral ribonucleotide reductase'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1997Patents assigned to BIO MEGA BOEHRINGER INGELHEIM (4)· patent assignee history
1995–2001Based in Laval, CA· patent location history
1997Based in Danbury, CT, US· patent location history
1998–2001Patents assigned to BOEHRINGER INGELHEIM CA LTD (3)· patent assignee history
2000–2010Patents assigned to BOEHRINGER INGELHEIM PHARMA (23)· patent assignee history
2000–2013Based in Ridgefield, CT, US· patent location history
2005Based in Ridegefield, CT, US· patent location history
2013Patents assigned to BOEHRINGER INGELHEIM INT (2)· patent assignee history
2013Patents assigned to COGAN DEREK (2)· patent assignee history
2020Based in Salt Lake City, UT, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM PHARMA232000–2010
BIO MEGA BOEHRINGER INGELHEIM41995–1997
BOEHRINGER INGELHEIM CA LTD31998–2001
BOEHRINGER INGELHEIM INT22013
COGAN DEREK22013
Locations
LocationPatentsSpan
Ridgefield, CT, US242000–2013
Laval, CA71995–2001
Salt Lake City, UT, US12020
Ridegefield, CT, US12005
Danbury, CT, US11997